Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder

Objectives: Describe the safety and tolerability of lisdexamfetamine dimesylate (LDX) and provide data on clinical effects for efficacy-related endpoints and pharmacokinetics in preschool-aged children with attention-deficit/hyperactivity disorder (ADHD). Methods: This phase 2, multicenter, open-lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Childress, Ann C., Findling, Robert L., Wu, James, Kollins, Scott H., Wang, Yi, Martin, Patrick, Robertson, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153646/
https://www.ncbi.nlm.nih.gov/pubmed/32233956
http://dx.doi.org/10.1089/cap.2019.0117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153646/
https://www.ncbi.nlm.nih.gov/pubmed/32233956
http://dx.doi.org/10.1089/cap.2019.0117

Ejemplares similares